Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC is a research paper published in Neuro-Oncology (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NINDS
Grant: R01-NS124607
NINDS
Grant: R01-NS119231
Department of Defense
Grant: CA201129P1
NINDS NIH HHS
Grant: R01 NS119231
NINDS NIH HHS
Grant: R01 NS124607
National Institutes of Health
Grant: 5R01NS124607-03
Targeting EGFR/FOXG1-mediated resistance to ONC201 in H3K27M-mutant diffuse midline glioma
National Institutes of Health
Grant: 5R01NS119231-04
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
Rogel Cancer Center and Hyundai Hope on Wheels
Bristol Myers Squibb Foundation Robert A. Winn Career Development Award
PNOC foundation
NIH
Chad Tough Defeat DIPG
Storm the Heavens
École Polytechnique Fédérale de Lausanne
FWCI
0.50
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals